肝脏免疫图谱揭示单核细胞来源巨噬细胞是脂肪性肝炎和胆管病进展的关键驱动因素
本研究结合转录组学与组织学方法,在3个独立队列中对人肝样本进行RNA测序(n=225)和成像流式细胞术(n=99),旨在空间解析NAFLD(包括NASH、原发性硬化性胆管炎、原发性胆汁性胆管炎和重度酒精性肝炎)的肝脏免疫微环境,发现IBA1+CD163低表达巨噬细胞聚集与疾病进展密切相关。
要点
- NAFLD/NASH和原发性硬化性胆管炎疾病分期与实质区丢失、胆管细胞积聚及免疫细胞浸润相关。
- NASH患者以髓系细胞积聚为主,原发性硬化性胆管炎患者还表现出显著的淋系细胞反应。
- IBA1+CD163低表达巨噬细胞在非实质区聚集并靠近胆管细胞,小鼠模型显示其起源于骨髓来源单核细胞。
核心结论
- 肝细胞丢失和胆管反应增加与单核细胞来源巨噬细胞积聚紧密相关,是NAFLD、原发性硬化性胆管炎、原发性胆汁性胆管炎和酒精性肝炎进展的最突出共同免疫特征。
- 提示IBA1+CD163低表达巨噬细胞是不同病因人肝病进展的关键致病驱动因素。
研究设计与样本
- 人肝样本进行RNA测序(n=225)和成像流式细胞术(n=99),涵盖3个独立患者队列。
- 使用酒精性肝炎和原发性胆汁性胆管炎患者肝样本作为对照。
- 在相应小鼠模型中进一步表征髓系细胞群体。
- 结合影像、临床和表型数据进行多维分析。
主要发现
- NAFLD/NASH和原发性硬化性胆管炎疾病分期与实质区丢失、胆管细胞积聚增加及免疫细胞浸润相关。
- NASH患者主要表现为髓系细胞积聚,而原发性硬化性胆管炎患者还伴有显著的淋系细胞反应。
- 两种病因均显示IBA1+CD16低表达CD163低表达巨噬细胞在非实质区强烈聚集,与疾病分期相关,且与胆管细胞空间上紧密邻近。
- 小鼠模型揭示疾病相关IBA1+肝巨噬细胞起源于骨髓来源单核细胞。
- 基于机器学习的无偏算法显示,IBA1联合肝细胞和胆管细胞免疫染色可预测人NASH、原发性硬化性胆管炎和酒精性肝炎的晚期肝硬化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The progression of chronic liver diseases towards liver cirrhosis is accompanied by drastic tissue changes. This study combines elaborate transcriptomic and histological methods aiming at spatially resolving the hepatic immune microenvironment in NAFLD (including NASH, primary sclerosing cholangitis, primary biliary cholangitis, and severe alcoholic hepatitis). APPROACH AND RESULTS: Human liver samples were subjected to RNA-sequencing (n=225) and imaging cytometry (n=99) across 3 independent patient cohorts. Liver samples from alcoholic hepatitis and primary biliary cholangitis patients were used for comparison. Myeloid populations were further characterized in corresponding mouse models. Imaging, clinical, and phenotypical data were combined for multidimensional analysis. NAFLD/NASH and primary sclerosing cholangitis disease stages were associated with loss of parenchymal areas, increased ductular cell accumulation, and infiltration of immune cells. NASH patients predominantly exhibited myeloid cell accumulation, whereas primary sclerosing cholangitis patients additionally had pronounced lymphoid cell responses. Correlating to disease stage, both etiologies displayed intense IBA1 + CD16 low CD163 low macrophage aggregation in nonparenchymal areas, with a distinct spatial proximity to ductular cells. Mouse models revealed that disease-associated IBA1 + hepatic macrophages originated from bone marrow-derived monocytes. Using an unbiased, machine learning-based algorithm, IBA1 in combination with hepatocyte and ductular cell immunostaining-predicted advanced cirrhosis in human NASH, primary sclerosing cholangitis, and alcoholic hepatitis. CONCLUSIONS: Loss of hepatocytes and increased ductular reaction are tightly associated with monocyte-derived macrophage accumulation and represent the most prominent common immunological feature revealing the progression of NAFLD, primary sclerosing cholangitis, primary biliary cholangitis, and alcoholic hepatitis, suggesting IBA1 + CD163 low macrophages are key pathogenic drivers of human liver disease progression across diverse etiologies.
引用
- Guillot A, Winkler M, Silva Afonso M, et al. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression. Hepatology. 2023. PMID: 36630995. doi:10.1097/HEP.0000000000000270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。